Navigation Links
FDA Grants Orphan Drug Designation to Omeros' OMS824 for Huntington's Disease
Date:9/30/2013

elerate the development of OMS824 and recognizes the important work conducted at Omeros," stated Gregory A. Demopulos, M.D., chairman and chief executive officer of Omeros. "The manifestations of Huntington's are devastating to both Huntington's patients and their families, yet there is only one currently approved therapeutic and it is focused on a single symptom of the disease. OMS824 holds the promise of expanding treatment across the constellation of debilitating effects of Huntington's. We look forward to working with the FDA to advance the clinical evaluation of OMS824 in patients suffering from Huntington's disease and plan to initiate enrollment in a Phase 2 trial later this year."

About Omeros' PDE10 Program
PDE10 is an enzyme that is expressed in areas of the brain linked to diseases that affect cognition and psychomotor functions, including Huntington's disease and schizophrenia. Huntington's disease is a hereditary neurodegenerative disorder that leads to movement, cognition, and behavioral abnormalities and premature death. Schizophrenia is a group of severe brain disorders characterized by an abnormal interpretation of reality, which can manifest as delusions, hallucinations, and/or disordered thinking and behavior. Cognitive dysfunction is responsible for substantial disability in both of these diseases and is not meaningfully improved by current medications. Omeros' proprietary compound OMS824 inhibits PDE10 and is being developed for the treatment of cognitive disorders. In addition to potential benefits on cognition, OMS824 could also improve the motor and psychiatric abnormalities in Huntington's disease as well as the positive (e.g., hallucinations) and negative (e.g., flat affect) symptoms of schizophrenia.

About Omeros Corporation
Omeros is a clinical-stage biopharmaceutical company committed to discovering, developing and commercializing small-molecule and protein therapeutics targeting inflam
'/>"/>

SOURCE Omeros Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Nektar Announces that FDA Grants Fast Track Designation to NKTR-181, a New Oral Opioid Analgesic Molecule, for the Treatment of Moderate to Severe Chronic Pain
2. Community Foundation Announces $2.6 Million In Grants From Centinela Medical Funds
3. U.S. FDA Grants Priority Review to the New Drug Application for Bayers Regorafenib to Treat Patients with Metastatic Colorectal Cancer
4. European Commission Grants Orphan Medicinal Product Designation for Emmaus Medicals Sickle Cell Treatment
5. FDA Grants Orphan Drug Designation To GeNO LLC For Use Of Inhaled Nitric Oxide In Treatment Of Persistant Pulmonary Hypertension Of The Newborn (PPHN)
6. Rep. Fattah Announces More Than $10.7 Million in Grants for Neuroscience, Scientific and Medical Research in Philadelphia
7. U.S. FDA Grants Priority Review to Bedaquiline (TMC207) for Multi-Drug Resistant Tuberculosis Treatment
8. Neuralstem Grants First Licenses For CNS Therapy Surgical Devices
9. EMA Grants Orphan Designation to Edison Pharmaceuticals for EPI-743 for Treatment of Leigh Syndrome
10. As Global Telemedicine Market Reaches $2.5 Billion, Industry Leaders Gather in San Diego to Discuss Grants, Funding, Vendor Selection, Credentialing, and More
11. Nektar Announces that FDA Grants Fast Track Designation to Etirinotecan Pegol (NKTR-102) for the Treatment of Metastatic Breast Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/4/2015)... , Aug. 4, 2015  Delcath Systems, Inc. (NASDAQ: ... company focused on oncology with an emphasis on the ... two abstracts summarizing data from studies in ... the Delcath Hepatic CHEMOSAT ® Delivery System (CHEMOSAT) will ... Oncology (EADO) annual congress, which will be held in ...
(Date:8/4/2015)... DIEGO , Aug. 4, 2015 ... three-dimensional biology company focused on delivering scientific and ... that the Company has hired Paul Gallant ... vitro tissue service and product business. Mr. Gallant has ... experience in the drug discovery industry, most recently ...
(Date:8/4/2015)... , Aug. 4, 2015  Mirati Therapeutics, Inc. ("Mirati") (NASDAQ: ... and epigenetic drivers of cancer, will be presenting at the ... at 1:55 p.m. ET (10:55 a.m. PT) in ... Ph.D., president and CEO of Mirati, will provide a corporate ... will be accessible on the "Investors" page of Mirati,s corporate ...
Breaking Medicine Technology:Delcath Announces Acceptance of Abstracts for Presentation at the European Association of Dermato Oncology Annual Congress 2Delcath Announces Acceptance of Abstracts for Presentation at the European Association of Dermato Oncology Annual Congress 3Delcath Announces Acceptance of Abstracts for Presentation at the European Association of Dermato Oncology Annual Congress 4Organovo Holdings, Inc. Appoints Paul Gallant as General Manager 2Organovo Holdings, Inc. Appoints Paul Gallant as General Manager 3Mirati Therapeutics To Present At The 2015 Wedbush PacGrow Healthcare Conference 2Mirati Therapeutics To Present At The 2015 Wedbush PacGrow Healthcare Conference 3
... Designs, a company specializing in fashionable medical ID bracelets ... available in an additional 1,100 pharmacies by the end of ... products to more than 1,800. The company ... offering stylish key chains, necklaces, flash drives and bracelets available ...
... 2011 A new prostate cancer study ... surgical treatment to "watchful waiting" revealed important findings ... currently debating their treatment options. (Photo:   ... offered clinical options for early prostate cancer treatment ...
Cached Medicine Technology:Robotic Prostatectomy Expert Dr. David Samadi on a High Impact Study Advocating Aggressive Early-Stage Prostate Cancer Treatment 2Robotic Prostatectomy Expert Dr. David Samadi on a High Impact Study Advocating Aggressive Early-Stage Prostate Cancer Treatment 3
(Date:8/4/2015)... ... August 05, 2015 , ... ... Stevens as a 2015-2016 inductee into its VIP Woman of the Year ... is the nation’s leading networking organization exclusively for professional women, boasting more than ...
(Date:8/4/2015)... ... August 05, 2015 , ... The Journal of Pain ... ”. , As corresponding author Professor Akiko Okifuji says “Both obesity and chronic pain ... is not to say that one causes the other. Rather, there appear to be ...
(Date:8/4/2015)... (PRWEB) , ... August 04, 2015 , ... ... technology platform that uses Cloud innovation to consolidate oncology patient assistance programs. Through ... a single point of access. assistPoint is an enterprise level, cloud-based application and ...
(Date:8/4/2015)... ... August 04, 2015 , ... Wimbledon Health ... echocardiogram, and NCV testing, announced their collegiate division, Wimbledon U , continues ... abnormalities one program at a time. , “Wimbledon U welcomes the ...
(Date:8/4/2015)... ... , ... Bayco Products, Inc. announces a new industrial-grade LED Dual-LightTM headlamp in ... that have a flip-up face shield. The sleek contours of the new Nightstick ... remove their headlamp when raising or lowering their face shield or visor. The 4614 ...
Breaking Medicine News(10 mins):Health News:NAPW Inducts Deborah Stevens, Executive Assistant to Chairman and CEO at Mirion Technologies, Inc., Into its VIP Woman of the Year Circle 2Health News:The Association between Chronic Pain and Obesity published by Dove Medical Press 2Health News:assistPoint.com Web Site Launched 2Health News:Colleges and High Schools Across the Country Are Joining the Wimbledon U Team Uncovering Unknown Cardiac Conditions and Promoting Heart Healthy Athletes 2Health News:Colleges and High Schools Across the Country Are Joining the Wimbledon U Team Uncovering Unknown Cardiac Conditions and Promoting Heart Healthy Athletes 3Health News:New Nightstick® NSP-4614B Dual-LightTM Headlamp fits more functionality into more places 2Health News:New Nightstick® NSP-4614B Dual-LightTM Headlamp fits more functionality into more places 3
... CREEK, Fla., Feb. 26 AlertSite(R), a leading,provider ... businesses,ensure optimum web experiences for their customers, announced ... site monitoring service.,iHerb.com is a major online retailer ... was recently name by ConsumerLab.com as the #1 ...
... Sponsorship of the 6th Annual Medical Banking Institute, highlights company,s ... ... and services platform, DALLAS, Feb. 26 BancTec, a ... is joining with,other industry leaders in an effort to improve ...
... as a Service, Innovation and Customer-Focused Approach to ... Artromick International, Inc.,a leading developer of medication ... acute care markets, today announced Edwin,Miller has joined ... Group.,In his new role, Miller is responsible for ...
... NEW YORK, Feb. 26 With over five million ... million new cases,diagnosed every year, it is the number ... accounting for a yearly direct cost of care,estimated at ... Failure: Worldwide Device Markets., Improvements in the care ...
... Capabilities, and New Architecture Position Solution as ... Market Leader, STAMFORD, ... the latest update to its Order Sets,Solution, which now includes:, ... market. -- Tools to create, edit, and maintain large ...
... Rx, a,wholly owned subsidiary of TeamStaff, Inc. ... Seal of Approval(TM) for health care staffing ... Healthcare Organizations ("JCAHO")., The JCAHO review ... processes, performance evaluations, education processes,and information management ...
Cached Medicine News:Health News:Top Nutritional Supplement Online Retailer, iHerb.com, Selects AlertSite for Web Site Performance Monitoring 2Health News:BancTec Takes Leadership Position in Helping to Create Better Value, Lower Transaction Costs in Healthcare Industry 2Health News:BancTec Takes Leadership Position in Helping to Create Better Value, Lower Transaction Costs in Healthcare Industry 3Health News:Artromick Names Edwin Miller President of Software Products Group 2Health News:'Hidden Epidemic' of Congestive Heart Failure Driving Hospitalization, Costs 2Health News:Thomson Healthcare Announces Enhancements to Order Sets Solution 2Health News:Thomson Healthcare Announces Enhancements to Order Sets Solution 3Health News:TeamStaff Rx Awarded JCAHO Certification 2Health News:TeamStaff Rx Awarded JCAHO Certification 3
... is a unique microprocessor controlled shaking incubator ... either 96 or 384 well format. Speed, ... control panel and all are displayed on ... the clear protective cover. The Millennium 2000 ...
... the only four-color, automated benchtop flow cytometry ... cell sorting. Designed specifically to support a ... offers software instrument control, auto-sample loading, and ... productivity. FACSCalibur is fully modular so it ...
... Ultracompact high end desktop multilaser flow ... any kind of cell analysis and absolute ... forward and two different side scatter signals ... channels. The new CyFlow ML instrument can ...
This unique system combines the analytical power of a research cytometer into a compact, truly walk away, clinical analyzer ergonomically designed to expedite sample throughput....
Medicine Products: